This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
(No authors listed) (2003) NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 19: 1–46
Backmund M et al. (2003) Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol 18: 563–538
Sylvestre DL (2005) Treating hepatitis C virus infection in active substance users. Clin Infect Dis 40 (Suppl 5): S321–S324
Schaefer M et al. (2004) Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 99: 1167–1175
Edlin BR (2002) Prevention and treatment of hepatitis C in injection drug users. Hepatology 36 (Suppl 1): S210–S219
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Patel, K. Is compliance with antiviral therapy for chronic hepatitis C lower in intravenous drug users?. Nat Rev Gastroenterol Hepatol 3, 368–369 (2006). https://doi.org/10.1038/ncpgasthep0547
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0547